Stay updated on Idasanutlin Combo in AML: Clinical Trial
Sign up to get notified when there's something new on the Idasanutlin Combo in AML: Clinical Trial page.

Latest updates to the Idasanutlin Combo in AML: Clinical Trial page
- Check4 days agoChange DetectedUpdated to Revision v3.0.2, replacing the old v3.0.1; removed the 'Back to Top' element as a minor UI cleanup.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check18 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the introduction of new drug-related terms. Notably, the content related to acute myeloid leukemia has been retained, while several previous terms and locations have been removed.SummaryDifference8%
- Check26 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.3%
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
Stay in the know with updates to Idasanutlin Combo in AML: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo in AML: Clinical Trial page.